Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
Previous court cases concerning informed consent of treatment have raised questions about what consent means in relation to pharmacists, medicines and prescribing.
Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.
William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.
Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.
In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.
UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription
If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.
Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription
Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.
Defining clinical pharmacy: a new paradigm Subscription
Amid the rapid change and evolution of pharmacy, now is the time to redefine what clinical pharmacy means.
Q&A: From training surgeons in Ireland to providing healthcare education internationallySubscription
Paul Gallagher, head of the school of pharmacy at the Royal College of Surgeons in Ireland, speaks to Benedict Lam about how the royal college focus on education and training led to the expansion of its provision of healthcare education in Ireland and beyond.
Time to redefine pharmacy researchSubscription
There is no universal definition of pharmacy research, and this may be one of the reasons for poor quality research in the sector.
Nicola Magrini from the World Health Organization discusses improving access to affordable medicines for non-communicable diseases and warns that treatments for cancer lag behind.
Pharmacists and opticians should work together to better manage patients with dry eye within primary care, with one local scheme serving as a model for pharmacists to refer patients to opticians when necessary.
Roles such as procurement are important in hospital pharmacy services and should not be brushed aside.
Luiz Loures from the Joint United Nations Programme on HIV/AIDS (UNAIDS) talks about ending the epidemic, and the challenges in fighting the disease that has claimed over 34 million lives.
There are many barriers to overcome to ensure best practice is shared more widely on an international level.
Katherine Murphy discusses the current crisis gripping the NHS and where pharmacists can fit in to help, and explains why safety, accountability and transparency are key priorities for the NHS.
Disclosing clinical trial data is a step in the right direction towards transparency, which benefits both the public and the pharmaceutical industry.
Q&A: V Craig Jordan — the father of tamoxifenSubscription
V Craig Jordan, Dallas/Fort Worth living legend chair of cancer research, professor of both breast medical oncology and molecular and cellular oncology at the University of Texas MD Anderson Cancer Center in Houston, is best known as “the father of tamoxifen”.
Should the UK remain a member of the European Union or should it leave? We put two opposing views together to help you decide.
After seven years in the pharmacy world, Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society to enter pastures new at the Royal Society of Medicine. Here, she talks to Julia Robinson about her proudest moments and what advice she would give to her successor.
Catherine Duggan, director of professional development at the Royal Pharmaceutical Society (RPS) and Ian Bates, education adviser to the RPS English Pharmacy Board, discuss the importance of developing a global standard of education and training for pharmacists.
The 2017 Royal Pharmaceutical Society (RPS) budget, agreed in November 2016, includes a financial surplus of £5,000 before interest. Here Simon Redman, director of finance at the RPS, talks to Julia Robinson about how the RPS has recovered from last year’s budgeted loss of £1.5m and what plans are being made to improve services and engage with members in the coming year.
Sandra Gidley, chair of the RPS English Pharmacy Board, makes the case for the integration of health and social care funding and explains why pharmacists are needed across the entire health and social care system and at all levels of the NHS.
David Branford, member of the Royal Pharmaceutical Society (RPS) English Pharmacy Board, and Dolly Sud, specialist mental health pharmacist Leicestershire Partnership NHS Trust, explain the importance of the role of pharmacists in improving the physical well-being of patients with severe mental illness.
Pharmacists can help improve the care of patients with long-term conditions across Great BritainSubscription
On 3 November 2016, the RPS launched its campaign on long-term conditions. Here, the chairs of the three RPS national pharmacy boards highlight the significance of the campaign and how it needs to be actioned in their respective countries.
Why RPS members should attend the FIP World Congress of Pharmacy and Pharmaceutical SciencesSubscription
Royal Pharmaceutical Society (RPS) English Pharmacy Board vice chair, Claire Anderson, reflects on her experience of the 2016 International Pharmaceutical Federation World Congress and explains why she feels there is professional value in RPS members attending, particularly when it comes to Glasgow in 2018.
What is the Falsified Medicines Directive? Subscription
Aileen Bryson, practice and policy lead at RPS Scotland, speaks to Julia Robinson about the purpose of the Falsified Medicines Directive and how it will affect pharmacists in the UK.
In 2015, the Royal Pharmaceutical Society signed an agreement with the Japanese Pharmaceutical Association promising to work together and share best practice on patient care and professional development. Here, Julia Robinson talks to Naoko Arakawa, the international programme lead at the RPS, about the collaboration so far.
Member of the RPS English Pharmacy Board Aamer Safdar makes the case for using benchmarking to help realise savings in line with the Carter review.